EI
RPTP

EAM Investors’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

EAM Investors’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-175,761
Closed -$2.63M – 429
2013
Q3 		$2.63M Sell
175,761
-48,216
-22% -$578K 0.52% 36
2013
Q2 		$2.09M Buy
+223,977
New +$1.52M 0.45% 52

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

EAM Investors's RPTP Position: Q4 2013 in Review

EAM Investors sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2013, closing a stake of 175,761 shares — an estimated $2.63M sold.

EAM Investors first reported a position in RPTP in Q2 2013 and held it in 2 quarters. The position peaked at $2.63M in Q3 2013. 68 funds tracked by Wall St. Rank hold RPTP as of Q4 2013.

  • EAM Investors reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2013 after selling out during the quarter.
  • EAM Investors sold 175,761 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2013, an estimated $2.63M.
  • EAM Investors first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 2 quarters.
  • EAM Investors's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.63M in Q3 2013.
  • 68 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2013.

Based on EAM Investors's 13F filing for Q4 2013, filed 14 Feb 2014.